Solstein Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $985K | Hold |
1,964
| – | – | 0.34% | 64 |
|
|
2026
Q1 | $965K | Sell |
1,964
-1,700
| -46% | -$923K | 0.4% | 60 |
|
|
2025
Q4 | $2.12M | Hold |
3,664
| – | – | 0.85% | 30 |
|
|
2025
Q3 | $1.78M | Sell |
3,664
-65
| -2% | -$30.3K | 0.4% | 32 |
|
|
2025
Q2 | $1.51M | Sell |
3,729
-852
| -19% | -$356K | 0.78% | 30 |
|
|
2025
Q1 | $2.28M | Hold |
4,581
| – | – | 1.33% | 18 |
|
|
2024
Q4 | $2.38M | Hold |
4,581
| – | – | 1.33% | 16 |
|
|
2024
Q3 | $2.83M | Sell |
4,581
-74
| -2% | -$43.8K | 1.5% | 17 |
|
|
2024
Q2 | $2.57M | Hold |
4,655
| – | – | 1.68% | 14 |
|
|
2024
Q1 | $2.71M | Sell |
4,655
-153
| -3% | -$85.9K | 1.88% | 13 |
|
|
2023
Q4 | $2.55M | Sell |
4,808
-125
| -3% | -$60.5K | 1.89% | 12 |
|
|
2023
Q3 | $2.5M | Sell |
4,933
-18
| -0.4% | -$9.59K | 2.15% | 11 |
|
|
2023
Q2 | $2.58M | Buy |
4,951
+46
| +0.9% | +$24.8K | 2.15% | 11 |
|
|
2023
Q1 | $2.83M | Sell |
4,905
-341
| -7% | -$192K | 2.46% | 9 |
|
|
2022
Q4 | $2.89M | Sell |
5,246
-384
| -7% | -$203K | 2.42% | 9 |
|
|
2022
Q3 | $2.85M | Buy |
5,630
+92
| +2% | +$51.5K | 2.52% | 8 |
|
|
2022
Q2 | $3.01M | Sell |
5,538
-55
| -1% | -$30.3K | 2.3% | 7 |
|
|
2022
Q1 | $3.3M | Sell |
5,593
-327
| -6% | -$188K | 2.18% | 11 |
|
|
2021
Q4 | $3.95M | Buy |
5,920
+1
| +0% | +$624 | 2.38% | 6 |
|
|
2021
Q3 | $3.38M | Buy |
5,919
+3,710
| +168% | +$2.04M | 1.94% | 7 |
|
|
2021
Q2 | $1.11M | Buy |
2,209
+177
| +9% | +$83.5K | 1.37% | 17 |
|
|
2021
Q1 | $927K | Buy |
2,032
+82
| +4% | +$39.1K | 1.26% | 22 |
|
|
2020
Q4 | $911K | Sell |
1,950
-942
| -33% | -$442K | 0.38% | 13 |
|
|
2020
Q3 | $1.28M | Sell |
2,892
-222
| -7% | -$91.7K | 2.86% | 7 |
|
|
2020
Q2 | $1.13M | Sell |
3,114
-447
| -13% | -$150K | 2.68% | 6 |
|
|
2020
Q1 | $1.01M | Sell |
3,561
-1,771
| -33% | -$558K | 3.89% | 8 |
|
|
2019
Q4 | $1.73M | Buy |
5,332
+3,060
| +135% | +$928K | 3.49% | 6 |
|
|
2019
Q3 | $641K | Buy |
2,272
+72
| +3% | +$20.6K | 5.69% | 7 |
|
|
2019
Q2 | $646K | Buy |
2,200
+1,000
| +83% | +$275K | 4.14% | 8 |
|
|
2019
Q1 | $328K | Hold |
1,200
| – | – | 1.85% | 18 |
|
|
2018
Q4 | $269K | Buy |
+1,200
| New | +$282K | 1.57% | 19 |
|
Other funds holding TMO
Solstein Capital's TMO Position: Q2 2026 in Review
Solstein Capital held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,964 shares worth $985K. The position accounts for 0.34% of the portfolio, ranked #64.
Solstein Capital first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.95M in Q4 2021. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Solstein Capital held 1,964 shares of Thermo Fisher Scientific worth $985K as of Q2 2026.
- Solstein Capital left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.34% of Solstein Capital's portfolio in Q2 2026, its #64 holding.
- Solstein Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
- Solstein Capital's Thermo Fisher Scientific position peaked at $3.95M in Q4 2021.
- 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.